Walt Perlt
Ask VT AI
View News Summary
- Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.
- Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
- Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Eagles trade for Jets CB Michael Carter II to bolster their secondary for a title defense.
- Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
- Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Walt Perlt
News from Walt Perlt
